The Moyamoya Disease Pathophysiology Explained
The Moyamoya Disease Pathophysiology Explained Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of arteries at the base of the brain, specifically the internal carotid arteries and their main branches. This condition leads to the development of a network of tiny, fragile blood vessels attempting to bypass the blocked arteries, creating a distinctive “puff of smoke” appearance on imaging studies, which is where the name “moyamoya” originates from in Japanese.
The pathophysiology of Moyamoya disease begins with a process of intimal hyperplasia, where the innermost layer of the arterial wall thickens abnormally. This thickening causes progressive stenosis or narrowing of the large cerebral arteries, primarily the terminal portions of the internal carotid arteries. The exact cause of this hyperplasia remains unknown, but genetic factors seem to play a significant role, as the disease is more prevalent in certain populations, particularly in Japan, Korea, and China, and often runs in families.
As the primary arteries narrow, blood flow to the brain becomes compromised, particularly in regions supplied by these vessels. To compensate for reduced perfusion, the brain initiates a process called collateral formation. Small, fragile vessels develop in an attempt to reroute blood around the occluded arteries. These collateral vessels are often abnormal and tend to be very delicate, which makes them prone to rupture and hemorrhage. This compensatory mechanism, while initially beneficial, can become insufficient as the disease progresses, leading to ischemic events such as transient ischemic attacks (TIAs) or strokes.
Another critical aspect of Moyamoya disease is the formation of these abnormal collateral vessels, which are typically characterized histologically by proliferation of smooth muscle cells and thickening of the vessel wall. These changes further impede normal blood flow and increase the risk of hemorrhagic stroke due to vessel rupture. Hemorrhages are often a consequence of the fragile collateral vessels rupturing, especially under hypertension or other stressors.
The disease progresses in phases, starting with ischemic symptoms due to inadequate blood supply, especially in children. As the disease advances, patients may experience hemorrhagic strokes caused by rupture of the fragile collateral vessels. Over time, the ongoing stenosis and the pathological changes in vessel walls can lead to significant neurological deficits, cognitive impairment, and disability.
In summary, Moyamoya disease involves a complex interplay of arterial narrowing, abnormal collateral vessel formation, and vessel wall pathology. The progressive occlusion of major cerebral arteries triggers compensatory mechanisms that are often inadequate over time and carry significant risks, including ischemic and hemorrhagic strokes. Understanding these underlying processes is vital for early diagnosis and effective management, which often involves surgical revascularization procedures aimed at restoring adequate blood flow and preventing stroke.